Detalhe da pesquisa
1.
Virtual Management of Multiple Sclerosis: Providing Access or Just Phoning it in?
Can J Neurol Sci
; 51(1): 113-116, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37066757
2.
Health Canada drug approval process: a barrier to personalized care in multiple sclerosis.
Can J Neurol Sci
; : 1-12, 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38777804
3.
Videoconferencing and Multiple Sclerosis Management: Stopgap or Stay Tuned?
Can J Neurol Sci
; 49(3): 402-405, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33998416
4.
Translingual neurostimulation combined with physical therapy to improve walking and balance in multiple sclerosis (NeuroMSTraLS): Study protocol for a randomized controlled trial.
Contemp Clin Trials
; 127: 107142, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36878390
5.
Cost-consequence analysis of ofatumumab for the treatment of relapsing-remitting multiple sclerosis in Canada.
J Comp Eff Res
; 12(9): e220175, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37606897
6.
Does the use of the Bruton Tyrosine Kinase inhibitors and the c-kit inhibitor masitinib result in clinically significant outcomes among patients with various forms of multiple sclerosis?
Mult Scler Relat Disord
; 67: 104164, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36126539
7.
Use of natalizumab in persons with multiple sclerosis: 2022 update.
Mult Scler Relat Disord
; 65: 103995, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35810718
8.
Cost-Effectiveness Analysis of Ofatumumab for the Treatment of Relapsing-Remitting Multiple Sclerosis in Canada.
Pharmacoecon Open
; 6(6): 859-870, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36107307
9.
Interleukin-1 receptor antagonist: An exploratory plasma biomarker that correlates with disability and provides pathophysiological insights in relapsing-remitting multiple sclerosis.
Mult Scler Relat Disord
; 52: 103006, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34004435
10.
Anti-CV2/CRMP5 antibody-associated hemorrhagic leukoencephalomyelitis treated with steroids, intravenous immunoglobulin, plasmapheresis, and cyclophosphamide.
Mult Scler Relat Disord
; 40: 101964, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32044694
11.
Nonalcoholic Wernicke's encephalopathy.
CJEM
; 18(4): 309-12, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25985980